首页 | 本学科首页   官方微博 | 高级检索  
     

LncRNA CRNDE靶向miR-384影响结直肠癌细胞放射敏感性的研究
引用本文:孙献涛,练延帮,白杨,杨超,胡晟云,王贵宪. LncRNA CRNDE靶向miR-384影响结直肠癌细胞放射敏感性的研究[J]. 中华放射医学与防护杂志, 2019, 39(12): 893-898
作者姓名:孙献涛  练延帮  白杨  杨超  胡晟云  王贵宪
作者单位:郑州大学第一附属医院结直肠外科 450052,郑州大学第一附属医院放射科 450052,郑州大学第一附属医院结直肠外科 450052,郑州大学第一附属医院结直肠外科 450052,郑州大学第一附属医院结直肠外科 450052,郑州大学第一附属医院结直肠外科 450052
摘    要:目的 研究长链非编码RNA (Lnc RNA)结直肠肿瘤差异表达基因(CRNDE)对结直肠癌细胞放射敏感性的影响及其机制。方法 以结直肠癌HT-29细胞作为体外研究对象,转染CRNDE shRNA,实时定量PCR测定干扰效果。以8 Gy X射线照射转染CRNDE shRNA后的HT-29细胞,四甲基偶氮唑盐(MTT)比色法和流式细胞术分别检测细胞增殖和凋亡水平。平板克隆实验检测放射敏感性。生物信息学软件预测CRNDE与miR-384有互补结合位点,荧光素酶报告系统鉴定靶向关系。将CRNDE shRNA和miR-384 inhibitor共转染至HT-29细胞中,以8 Gy剂量照射处理,MTT和流式细胞术检测细胞增殖和凋亡变化。结果 CRNDE shRNA能够降低HT-29细胞中CRNDE表达水平(1.00±0.08 vs. 0.42±0.06,t=10.051,P<0.05)。CRNDE shRNA和放射均可以抑制HT-29细胞增殖并诱导细胞凋亡,并且二者联合具有协同作用[凋亡率:(2.27±0.13)%、(23.58±2.35)%、(26.91±2.81)%、(36.84±3.24)%,F=24.66,P<0.05;吸光度(A)值:0.45±0.060.30±0.02、0.28±0.03、0.20±0.02,F=106.21,P<0.05]。CRNDE shRNA转染后可以提高HT-29细胞放射敏感性,放射增敏比为1.374。CRNDE靶向负调控miR-384表达。miR-384 inhibitor能够拮抗CRNDE shRNA对放射处理的结直肠癌细胞增殖抑制和凋亡促进的作用。结论 下调LncRNA CRNDE表达可增强结直肠癌细胞的放射敏感性,其作用机制与靶向负调控miR-384表达有关。

关 键 词:结直肠癌  长链非编码RNA结直肠肿瘤差异表达基因  miR-384  放射敏感性
收稿时间:2019-03-04

Effect of lncRNA CRNDE targeting miR-384 on radiosensitivity of colorectal cancer cells
Sun Xiantao,Lian Yanbang,Bai Yang,Yang Chao,Hu Shengyun and Wang Guixian. Effect of lncRNA CRNDE targeting miR-384 on radiosensitivity of colorectal cancer cells[J]. Chinese Journal of Radiological Medicine and Protection, 2019, 39(12): 893-898
Authors:Sun Xiantao  Lian Yanbang  Bai Yang  Yang Chao  Hu Shengyun  Wang Guixian
Affiliation:Department of Colorectal Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, China,Department of Radiology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, China,Department of Colorectal Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, China,Department of Colorectal Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, China,Department of Colorectal Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, China and Department of Colorectal Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, China
Abstract:Objective To study the effect of LncRNA CRNDE on radiosensitivity of colorectal cells and underlying mechanism. Methods Colorectal cancer HT-29 cells were transfected with CRNDE shRNA and the interference efficiency was determined by Real time PCR. HT-29 cells transfected with CRNDE shRNA or co-transfected with CRNDE shRNA and miR-384 inhibitor were irradiated at 8 Gy dose, then cell proliferation and apoptosis were detected by MTT and flow cytometry assay, respectively, and cell radiosensitivity was evaluated by cloning assay. It was predicted by a bioinformatics software that CRNDE and miR-384 have complementary binding sites, and this was identified by a luciferase reporting system. Results CRNDE shRNA reduced the expression of CRNDE in HT-29 cells(1.00±0.08 vs. 0.42±0.06, t=10.051, P<0.05). Both CRNDE shRNA and radiation inhibited the proliferation and induced apoptosis of HT-29 cells, and their combination treatment had synergistic effect in apoptosis induction[Apoptosis rates:(2.27±0.13)%, (23.58±2.35)%, (26.91±2.81)%, (36.84±3.24)%,F=24.660,P<0.05;A values:0.45±0.06, 0.30±0.02, 0.28±0.03, 0.20±0.02, F=106.207, P<0.05]. Transfection of CRNDE shRNA increased the radiosensitivity of HT-29 cells with a radiosensitization ratio of 1.374. CRNDE negatively regulated the expression of its target miR-384. The miR-384 inhibitor antagonized the effect of CRNDE shRNA on proliferation inhibition and apoptosis promotion of radiation-treated colorectal cancer cells. Conclusions Down-regulation of LncRNA expression enhances the radiosensitivity of colorectal cancer cells by regulating miR-384 expression.
Keywords:Colorectal cancer  Colorectal neoplasia differentially expressed(CRNDE)  miR-384  Radiosensitivity
点击此处可从《中华放射医学与防护杂志》浏览原始摘要信息
点击此处可从《中华放射医学与防护杂志》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号